Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $40.22 million. The enterprise value is $56.36 million.
| Market Cap | 40.22M |
| Enterprise Value | 56.36M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 140.29 million shares outstanding. The number of shares has increased by 1.38% in one year.
| Current Share Class | 140.29M |
| Shares Outstanding | 140.29M |
| Shares Change (YoY) | +1.38% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 12.63% |
| Owned by Institutions (%) | 13.48% |
| Float | 54.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| Forward PS | 0.37 |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 70.56 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.16 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.99 |
Financial Efficiency
Return on equity (ROE) is -25.16% and return on invested capital (ROIC) is -10.17%.
| Return on Equity (ROE) | -25.16% |
| Return on Assets (ROA) | -3.75% |
| Return on Invested Capital (ROIC) | -10.17% |
| Return on Capital Employed (ROCE) | -11.06% |
| Weighted Average Cost of Capital (WACC) | 5.21% |
| Revenue Per Employee | $725,344 |
| Profits Per Employee | -$73,755 |
| Employee Count | 151 |
| Asset Turnover | 1.20 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, XTNT has paid $1.90 million in taxes.
| Income Tax | 1.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.86% in the last 52 weeks. The beta is -0.20, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -62.86% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 29.83 |
| Average Volume (20 Days) | 151,397 |
Short Selling Information
The latest short interest is 143,564, so 0.10% of the outstanding shares have been sold short.
| Short Interest | 143,564 |
| Short Previous Month | 1.83M |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.26% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, XTNT had revenue of $109.53 million and -$11.14 million in losses. Loss per share was -$0.08.
| Revenue | 109.53M |
| Gross Profit | 65.05M |
| Operating Income | -5.50M |
| Pretax Income | -9.24M |
| Net Income | -11.14M |
| EBITDA | -1.47M |
| EBIT | -5.50M |
| Loss Per Share | -$0.08 |
Balance Sheet
The company has $9.87 million in cash and $26.01 million in debt, with a net cash position of -$16.14 million or -$0.12 per share.
| Cash & Cash Equivalents | 9.87M |
| Total Debt | 26.01M |
| Net Cash | -16.14M |
| Net Cash Per Share | -$0.12 |
| Equity (Book Value) | 40.02M |
| Book Value Per Share | 0.29 |
| Working Capital | 34.81M |
Cash Flow
In the last 12 months, operating cash flow was $570,000 and capital expenditures -$1.27 million, giving a free cash flow of -$696,000.
| Operating Cash Flow | 570,000 |
| Capital Expenditures | -1.27M |
| Depreciation & Amortization | 4.02M |
| Net Borrowing | -11.84M |
| Free Cash Flow | -696,000 |
| FCF Per Share | -$0.00 |
Margins
Gross margin is 59.39%, with operating and profit margins of -5.02% and -10.17%.
| Gross Margin | 59.39% |
| Operating Margin | -5.02% |
| Pretax Margin | -8.44% |
| Profit Margin | -10.17% |
| EBITDA Margin | -1.34% |
| EBIT Margin | -5.02% |
| FCF Margin | n/a |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.38% |
| Shareholder Yield | -1.38% |
| Earnings Yield | -27.69% |
| FCF Yield | -1.73% |
Analyst Forecast
The average price target for XTNT is $1.03, which is 259.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.03 |
| Price Target Difference | 259.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -3.90% |
| EPS Growth Forecast (3Y) | -28.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -1.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.73 |
| Piotroski F-Score | 3 |